BioCentury
ARTICLE | Clinical News

CYT-6091: Preliminary Phase I data

June 11, 2007 7:00 AM UTC

In an open-label, dose-escalation, U.S. Phase I trial there was about a 10-fold increase in the number of gold nanoparticles in tumors from 5 of 6 patients compared with adjacent healthy tissue. There...